AbbVie nears settlement covering 4,000-plus AndroGel cases by Eric Sagonowsky Tuesday, September 11, 2018 AndroGel plaintiffs and drugmaker AbbVie have progressed in settlement talks, and a judge stayed further proceedings so they can work out a deal.
Endo settles 1,300 testosterone liability lawsuits by Eric Sagonowsky Tuesday, June 12, 2018 Endo moved to resolve "all known" testosterone drug lawsuits it faced. The company last year set aside $200 million for the litigation.
AndroGel trial do-over slashes AbbVie damages to $3M by Eric Sagonowsky Tuesday, March 27, 2018 AbbVie scored a major reduction of damages in a retrial of an AndroGel liability case brought by plaintiff Jesse Mitchell.
Endo scores a victory in its first testosterone bellwether case by Arlene Weintraub Friday, November 17, 2017 Endo received good news this week in a lawsuit alleging wrongdoing in how it marketed its testosterone drug Testim.
Judge limits suit against 'low-T' drugs but lets it go to trial by Eric Palmer Wednesday, May 17, 2017 A federal judge hearing the bellwether lawsuit for "low-T" drug marketing decided the plaintiff’s case was suffering from a lack of support for some of its claims.
